Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Epidemiological predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona |
Epidemiological data including demographic data, contact with COVD-19 positive patients and onset of symptoms. |
through study completion, an average of 3 months |
|
Primary |
Clinical predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona |
Underlying chronic diseases, signs/symptoms related with COVID-19 diseases an clinical presentation on admission |
through study completion, an average of 3 months |
|
Primary |
Body temperature (°C) on admission in COVID-19 patients admitted to University Hospital of Verona |
Body temperature (°C) |
through study completion, an average of 3 months |
|
Primary |
Blood pressure (mmHg) on admission in COVID-19 patients admitted to University Hospital of Verona |
Blood pressure (mmHg) |
through study completion, an average of 3 months |
|
Primary |
Pulse rate (beats per minute) on admission in COVID-19 patients admitted to University Hospital of Verona |
Pulse rate (beats per minute) |
through study completion, an average of 3 months |
|
Primary |
Respiratory rate (breaths per minute) on admission in COVID-19 patients admitted to University Hospital of Verona |
Pulse rate (beats per minute) |
through study completion, an average of 3 months |
|
Primary |
Peripheral oxygen saturation (%) on admission in COVID-19 patients admitted to University Hospital of Verona |
Peripheral oxygen saturation (%) |
through study completion, an average of 3 months |
|
Primary |
C reactive protein (CRP, m/gL) in COVID-19 patients admitted to University Hospital of Verona |
CRP (m/gL) |
through study completion, an average of 3 months |
|
Primary |
Procalcitonin (PCT, ng/mL) in COVID-19 patients admitted to University Hospital of Verona |
PCT (ng/mL |
through study completion, an average of 3 months |
|
Primary |
White Blood Count (WBC, cell/mm3) in COVID-19 patients admitted to University Hospital of Verona |
White Blood Count (WBC, cell/mm3) |
through study completion, an average of 3 months |
|
Primary |
Neutrophils (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona |
Neutrophils (cell/mm3) |
through study completion, an average of 3 months |
|
Primary |
Lymphocytes (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona |
Lymphocytes (cell/mm3) |
through study completion, an average of 3 months |
|
Primary |
Platelets (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona |
Platelets (cell/mm3) |
through study completion, an average of 3 months |
|
Primary |
L-lattato deidrogenasi (LDH, mU/ml) in COVID-19 patients admitted to University Hospital of Verona |
LDH (mU/ml) |
through study completion, an average of 3 months |
|
Primary |
Creatine kinase (CK, U/L) in COVID-19 patients admitted to University Hospital of Verona |
CK (U/L) |
through study completion, an average of 3 months |
|
Primary |
D-dimer (µg/L) in COVID-19 patients admitted to University Hospital of Verona |
D-dimer (µg/L) |
through study completion, an average of 3 months |
|
Primary |
fibrinogen (g/L) in COVID-19 patients admitted to University Hospital of Verona |
fibrinogen (g/L) |
through study completion, an average of 3 months |
|
Primary |
ferritin (mcg/L) in COVID-19 patients admitted to University Hospital of Verona |
ferritin (mcg/L) |
through study completion, an average of 3 months |
|
Primary |
AST (U/L) in COVID-19 patients admitted to University Hospital of Verona |
AST (U/L) |
through study completion, an average of 3 months |
|
Primary |
ALT (U/L) in COVID-19 patients admitted to University Hospital of Verona |
ALT (U/L) |
through study completion, an average of 3 months |
|
Primary |
Creatinine (mg/dl) in COVID-19 patients admitted to University Hospital of Verona |
Creatinine (mg/dl) |
through study completion, an average of 3 months |
|
Primary |
Arterial blood gas anaysis pH in COVID-19 patients admitted to University Hospital of Verona |
pH |
through study completion, an average of 3 months |
|
Primary |
Arterial blood gas anaysis pO2 (mmHg) in COVID-19 patients admitted to University Hospital of Verona |
pO2 (mmHg) |
through study completion, an average of 3 months |
|
Primary |
Arterial blood gas anaysis pCO2 (mmHg) in COVID-19 patients admitted to University Hospital of Verona |
pCO2 (mmHg) |
through study completion, an average of 3 months |
|
Primary |
Arterial blood gas anaysis HCO3 (mmol/l) in COVID-19 patients admitted to University Hospital of Verona |
HCO3 (mmol/l) |
through study completion, an average of 3 months |
|
Primary |
Arterial blood gas anaysis SpO2 (%) in COVID-19 patients admitted to University Hospital of Verona |
SpO2 (%) |
through study completion, an average of 3 months |
|
Primary |
Host-related factors associated with the pathogenesis of COVID-19 |
IL-6 (pg/mL) |
through study completion, an average of 3 months |
|
Primary |
Virological factors associated with the pathogenesis of COVID-19 |
Nasal and rectal swabs, fecal samples and blood samples |
through study completion, an average of 3 months |
|